Latest / Walker Crips' Market Commentary

Rising interest rates impact UK M&A activity
Dechra Pharmaceuticals, a business involved in the development and marketing of veterinary products, saw its share price increase approximately 15% last week. This was after a cash offer made by Freya Bidco Limited for the entire issued, and to be issued, ordinary share capital of Dechra for 3,875p per share. This represented a 44% premium to the closing price of 2,690 pence on the 12th April, the last business day before the commencement of the Offer Period...
Stocks featured:
Dechra Pharmaceuticals, B&M and Greencore
To find out more about the investment management services offered by…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.